Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study

INTRODUCTION: Clinical trials have shown that liraglutide effectively lowers glycated hemoglobin A1c (A1C) levels in adult patients with type 2 diabetes (T2D). However, no studies have evaluated the effectiveness of liraglutide by body mass index (BMI) in the United States (US) in clinical practice....

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Chitnis, Abhishek S., Ganz, Michael L., Benjamin, Nicole, Langer, Jakob, Hammer, Mette
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Healthcare 2014
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176953/
https://ncbi.nlm.nih.gov/pubmed/25245811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-014-0153-5
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन